What's happened
The Oropouche virus, known as 'sloth fever,' has been detected in Europe, with 19 cases reported in Spain, Italy, and Germany. The virus, primarily spread by midges, has raised health concerns, especially regarding its effects on pregnant women. Two fatalities have been confirmed in Brazil, marking the first deaths linked to this virus.
Why it matters
What the papers say
According to The Independent, the Oropouche virus, colloquially known as 'sloth fever,' has been reported in Europe for the first time, with 19 imported cases linked to travel in South America. The European Centre for Disease Control (ECDC) assessed the risk of infection for EU citizens as moderate, emphasizing the need for protective measures when traveling to affected areas. Metro highlights the alarming potential for the virus to become 'unstoppable,' especially given the recent fatalities in Brazil, which were the first known deaths from the virus. Sky News notes that the virus has been linked to severe outcomes in pregnant women, raising significant health concerns. Dr. Enny Paixao from the London School of Hygiene and Tropical Medicine stresses the importance of understanding the factors driving the recent outbreak, including climate change and enhanced surveillance.
How we got here
The Oropouche virus was first identified in Trinidad and Tobago in 1955 and has been circulating in South America and the Caribbean. Recent outbreaks in Brazil, Bolivia, Colombia, Peru, and Cuba have led to increased cases, prompting health alerts in Europe as travelers return from affected regions.
Common question
-
What is Sloth Fever and What Are Its Symptoms?
Sloth fever, scientifically known as the Oropouche virus, has recently emerged as a health concern in Europe, with cases linked to travel in South America. Understanding its symptoms, transmission, and risks is crucial for travelers and residents alike. Below, we address common questions about this virus to help you stay informed and safe.
-
What Health Alerts Should Travelers Be Aware Of?
Traveling can expose you to various health risks, especially with emerging diseases like the Oropouche virus. Staying informed about health alerts is crucial for your safety and well-being while abroad. Below are some common questions travelers have regarding health risks and how to prepare for them.
-
How Does the Oropouche Virus Impact Public Health?
The emergence of the Oropouche virus in Europe has raised significant public health concerns, particularly regarding its implications for health policies and responses. With cases linked to travel in South America, understanding the virus's effects and the lessons from past outbreaks is crucial for effective management and prevention strategies.
-
What are the latest trends in emerging infectious diseases?
As global travel increases and climate change alters ecosystems, emerging infectious diseases are becoming a pressing concern. The recent rise of the Oropouche virus in Europe highlights the need for awareness and preparedness. Here are some common questions about these trends and how they affect public health.
-
What is Sloth Fever and How is the Oropouche Virus Transmitted?
Sloth fever, caused by the Oropouche virus, has recently emerged in Europe, raising health concerns among travelers and residents alike. With cases reported in Spain, Italy, and Germany, understanding this virus is crucial. What are its symptoms? How can you protect yourself, especially if you're pregnant? Read on to find answers to these pressing questions.
-
What are the latest emerging viruses affecting Europe?
As new viruses emerge, public health concerns grow, especially in Europe where recent cases have been reported. Understanding these viruses, their origins, and the necessary precautions can help mitigate risks. Below are some common questions regarding the latest health threats and their implications.
More on these topics
-
Brazil, officially the Federative Republic of Brazil, is the largest country in both South America and Latin America. At 8.5 million square kilometers and with over 211 million people, Brazil is the world's fifth-largest country by area and the sixth most
-
Danny Altmann is a British immunologist, and Professor of Immunology at Imperial College London.
Altmann earned a bachelor's degree from the University of London in 1980, and a PhD from the University of Bristol in 1983 on T cell immunity to herpesviruses